Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice

Transplantation

Volumn 82, Issue 5, 2006, Pages 689-698

  Nagata, Shigeyuki ^a   Okano, Shinji ^a   Yonemitsu, Yoshikazu ^a   Nakagawa, Kazunori ^a   Tomita, Yukihiro ^a   Yoshikai, Yasunobu ^b   Shimada, Mitsuo ^c   Maehara, Yoshihiko ^a   Sueishi, Katsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Alloantibody; Bone marrow transplantation; Memory T cell; Rejection; Sensitized recipient

Indexed keywords

IMMUNOGLOBULIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BIOLOGICAL MODEL; BONE MARROW CELL; CELL TRANSFER; CHIMERA; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT REJECTION; IMMUNOLOGICAL MEMORY; MALE; MEMORY T LYMPHOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; SENSITIZATION; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE; WHOLE BODY RADIATION;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; IMMUNIZATION; IMMUNOLOGIC MEMORY; LYMPHOCYTE TRANSFUSION; MICE; MODELS, ANIMAL; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33748709826     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000235589.66683.0e     Document Type: Article

References (50)

1. Ringden O. Allogeneic bone marrow transplantation for hematological malignancies-controversies and recent advances. Acta Oncol 1997; 36(6): 549.
2. Young NS, Barrett AJ. The treatment of severe acquired aplastic anemia. Blood 1995; 85(12): 3367.
3. Gluckman E. Bone marrow transplantation in children with hereditary disorders. Curr Opin Pediatr 1996; 8(1): 42.
4. O'Marcaigh AS, Cowan MJ. Bone marrow transplantation for inherited diseases. Curr Opin Oncol 1997; 9(2): 126.
5. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335(6): 369.
6. Buckley RH. Advances in the understanding and treatment of human severe combined immunodeficiency. Immunol Res 2000; 22 (2-3): 237.
7. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307(5947): 168.
8. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153(3): 1087.
9. Tomita Y, Yoshikawa M, Zhang QW, et al. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide. J Immunol 2000; 165(1): 34.
10. Sykes M, Szot GL, Swenson KA, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997; 3(7): 783.
11. Ohlen C, Hoglund P, Sentman CL, et al. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Eur J Immunol 1995; 25(5): 1286.
12. Murphy WJ, Koh CY, Raziuddin A, et al. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev 2001; 181: 279.
13. Suzue K, Reinherz EL, Koyasu S. Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice. Eur J Immunol 2001; 31(11): 3147.
14. Hasegawa W, Lipton JH, Messner HA, et al. Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors. Hematology 2003; 8(1): 27.
15. Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320(4): 197.
16. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111(12): 1887.
17. Barge AJ, Johnson G, Witherspoon R, Torok-Storb B. Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood 1989; 74(5): 1477.
18. Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 1977; 296(2): 61.
19. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995; 16(9): 437.
20. Scornik JC, Elfenbein G, Graham-Pole J, et al. Role of anti-donor antibodies in bone marrow transplant rejection: evaluation by flow cytometry and effect of plasma exchanges. Transplant Proc 1989; 21 (1 Pt 3): 2974.
21. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11(7): 237.
22. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987; 165(4): 1212.
23. Sykes M, Sachs DH. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today 1988; 9(1): 23.
24. Colson YL, Li H, Boggs SS, et al. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 1996; 157(7): 2820.
25. Tomita Y, Sachs DH, Khan A, Sykes M. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 1996; 61(3): 469.
26. Komatsu M, Mammolenti M, Jones M, et al. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Blood 2003; 101(10): 3991.
27. Jones M, Komatsu M, Levy RB. Cytotoxically impaired transplant recipients can efficiently resist major histocompatibility complex-matched bone marrow allografts. Biol Blood Marrow Transplant 2000; 6 (4A): 456.
28. Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293(5528): 293.
29. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401(6754): 708.
30. Tewari K, Sacha J, Gao X, Suresh M. Effect of chronic viral infection on epitope selection, cytokine production, and surface phenotype of CD8 T cells and the role of IFN-gamma receptor in immune regulation. J Immunol 2004; 172(3): 1491.
31. Blander JM, Sant'Angelo DB, Metz D, et al. A pool of central memory-like CD4 T cells contains effector memory precursors. J Immunol 2003; 170(6): 2940.
32. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163(4): 2267.
33. Matesic D, Lehmann PV, Heeger PS. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998; 65(7): 906.
34. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol 2003; 21: 139.
35. Gould DS, Auchincloss H, Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999; 20(2): 77.
36. Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28(3): 638.
37. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation-rejection, infection, and coronary occlusive disease. Transplantation 1991; 52(2): 244.
38. Weiden PL, Storb R, Slichter S, et al. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol 1976; 117(1): 143.
39. Braun N, Faul C, Wernet D, et al. Successful transplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto protein A. Transplantation 2000; 69(8): 1742.
40. Smith BR, Guinan EC, Parkman R, et al. Efficacy of a cyclophosphamide- procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia. Transplantation 1985; 39(6): 671.
41. Charles A. Janeway J, Travers P, et al. Immunobiology, Chapter 9; The humoral immune response. Fifth Ed. New York: Garland Publishing, 2001.
42. Matsuoka S, Tsurui H, Abe M, et al. A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model. J Exp Med 2003; 198(3): 497.
43. Pluschke G, Bordmann G, Daoudaki ME, et al. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation. Eur J Immunol 1989; 19(1): 131.
44. Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 2003; 4(9): 835.
45. Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J Immunol 1988; 141(7): 2282.
46. Murphy WJ, Kumar V, Cope JC, Bennett M. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J Immunol 1990; 144(9): 3305.
47. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3(4): 269.
48. Krymskaya L, Lee WH, Zhong L, Liu CP. Polarized development of memory cell-like IFN-gamma-producing cells in the absence of TCR zeta-chain. J Immunol 2005; 174(3): 1188.
49. Ernst DN, Weigle WO, Noonan DJ, et al. The age-associated increase in IFN-gamma synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. J Immunol 1993; 151(2): 575.
50. Morelli AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003; 196: 125.